Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Irinotecan in Advanced Breast Cancer
NCT00275041Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2006
- Primary completion
- Feb 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of cetuximab in breast cancer, sponsored by Cancer and Leukemia Group B. Started Feb 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00275041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275041.